BLRX
BioLineRx Ltd.
$2.98
+0.07 (+2.41%)
At close · Jul 16
Market Cap
$13.41M
Shares
4,499,411
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$2.98
Open$3.07
Day$2.90–3.07
52W$2.15–4.75
Avg vol 30d22K
Short int137K · 3.0% float · 7.4d
Short vol11%
Last earningsSep 30, 2025
DataJan 2020–Jul 2026
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
Equibles Rating
blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical
Sell
Momentum
Weak
Sentiment
Neutral
Fundamentals
Limited
Quant / Vol
Very High
Market backdrop
VIX 16.7 · calm
Equity put/call 0.67
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−3%
below
Price vs 50-day avg
−6%
below
RSI (14)
44
neutral
MACD trend
Negative
52-week position
32%
mid-range
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
−2%
trailing
6-month return
+1%
trailing
YTD return
+8%
this year
Relative strength
−8%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $3 › 200d $3 — 50d above 200d
Institutional flow
Flat
0% holders QoQ · +2 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
3.04% of float · ▼ -5.9% MoM · 7.4 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
14 holders — mid 1-yr range
Squeeze score
66
elevated · 0–100
Fundamentals
Not enough data for a confident read.
Quant / Vol
risk profile
Volatility
62%
annualized · 1-yr
Max drawdown
−53%
past year
ATR
7.6%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−3%
Neutral
Price vs 50-day avg
−6%
Bearish
RSI (14)
44
Neutral
MACD trend
Negative
Bearish
52-week position
32%
Neutral
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bullish · 1 of 6
Trend (MA cross)
No cross
50d $3 › 200d $3 — 50d above 200d
Institutional flow
Flat
0% holders QoQ · +2 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
3.04% of float · ▼ -5.9% MoM · 7.4 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
14 holders — mid 1-yr range
Price context
position in its 52-week range
52-wk low $2
Now $3 · 32%
52-wk high $5
vs 200-day avg -3%
vs 50-day avg -6%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
BLRX
this stock
BioLineRx Ltd.
|
$13.41M | +7.6% | — | — | 3.0% |
|
ONC
BeOne Medicines Ltd.
|
$458.76B | +4.5% | +22179.2% | 933.6 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$123.36B | +7.2% | +46.2% | 28.8 | 1.9% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$71.18B | -11.9% | +20.8% | 16.6 | 3.3% |
|
ARGX
Argenx SE
|
$53.68B | +2.0% | — | — | 2.3% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Institutional Holders
Reducing
Holders
14
- % held
- 0.7%
- Net QoQ
- -41.6K sh
- Top holder
- XTX Topco Ltd
Held
Float
Short & Settlement
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| BLRX | -1.7% | -2.3% | +0.7% | -4.5% | +7.6% |
| SPY | -0.1% | +0.1% | +9.0% | +0.5% | +10.1% |
| vs SPY | -1.5% | -2.4% | -8.3% | -5.0% | -2.5% |